# Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on Dialysis

> **NCT03519243** · PHASE2 · COMPLETED · sponsor: **Biocad** · enrollment: 75 (actual)

## Conditions studied

- Anemia

## Interventions

- **BIOLOGICAL:** BCD-131
- **BIOLOGICAL:** Mircera

## Key facts

- **NCT ID:** NCT03519243
- **Lead sponsor:** Biocad
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-24
- **Primary completion:** 2018-12-01
- **Final completion:** 2018-12-10
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2021-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03519243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03519243, "Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on Dialysis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03519243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*